Improved pulmonary function in systemic sclerosis after treatment with cyclophosphamide.
about
Corticosteroids and the risk of scleroderma renal crisis: a systematic review.Scleroderma lung diseaseHigh-dose immunosuppressive therapy for severe systemic sclerosis: initial outcomesCurrent treatment options in systemic Sclerosis (Scleroderma).Lung involvement in systemic sclerosis.Mortality and causes of death in a Swedish series of systemic sclerosis patients.Disease severity of 100 patients with systemic sclerosis over a period of 14 years: using a modified Medsger scale.European multicentre study to define disease activity criteria for systemic sclerosis. I. Clinical and epidemiological features of 290 patients from 19 centres.Autologous stem cell transplantation in the treatment of systemic sclerosis: report from the EBMT/EULAR Registry.Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease.Scleroderma lung study (SLS): differences in the presentation and course of patients with limited versus diffuse systemic sclerosisBronchoalveolar lavage and response to cyclophosphamide in scleroderma interstitial lung diseaseTreatment of scleroderma-interstitial lung disease with cyclophosphamide is associated with less progressive fibrosis on serial thoracic high-resolution CT scan than placebo: findings from the scleroderma lung study.Interstitial lung disease in connective tissue diseases: evolving concepts of pathogenesis and management.Prevalence and factors associated with glucocorticoids (GC) use in systemic sclerosis (SSc): a systematic review and meta-analysis of cohort studies and registries.Current and emerging treatment options for interstitial lung disease in patients with rheumatic disease.Interstitial lung disease of systemic sclerosis.Effects of oral cyclophosphamide and prednisolone therapy on the endothelial functions and clinical findings in patients with early diffuse systemic sclerosis.Low-dose intravenous cyclophosphamide in systemic sclerosis: an open prospective efficacy study in patients with early diffuse disease.Interstitial lung disease associated with systemic sclerosis: what is the evidence for efficacy of cyclophosphamide?Scleroderma Lung DiseaseSystemic sclerosis: comparison of efficacy of oral cyclophosphamide and azathioprine on skin score and pulmonary involvement—a retrospective study
P2860
Q33763415-3FF3A302-8C9C-499F-984A-85F24798BB79Q33919119-174B8D6F-BD3F-4E7D-BF2B-D8BC4252FC5CQ34208626-94E9ECED-4664-424A-BEB8-710E3B3F5608Q34567929-D5699D09-4751-499D-9F8B-B2F8C9052CACQ34732817-AA043732-DA40-4855-A1F9-574F8EDFF51EQ35547607-112E4630-B81C-430D-B30A-E173DBEFEF03Q35549965-085C4495-7F6E-4BD1-9A0A-F620BFC52A4EQ35550528-013716C9-6E43-4B5A-86F3-1D52258EF3E5Q35554404-B328B667-CC86-4187-B7C7-7BBED1573186Q36145795-95853D37-0B3C-4AAD-BFD3-78D7E85450B4Q36171822-E973513C-C9DE-4855-A813-D213E361D6D3Q36330650-CBACF775-50B7-4DA7-ADE0-29F0F2618187Q37412005-F56CCF0A-2D85-4047-A235-125E4F8EFB44Q37782153-4FE76D33-6D69-430A-99F0-3187BD296B49Q38163917-D4262339-750B-4CDF-A420-C642023A8C08Q38692232-2D417547-6A8E-4DFE-BE29-C245CE0ED809Q40468554-37ECBD2C-D57D-4861-8973-0FBC9363373FQ44541027-C91A14BA-65BF-4D5C-A5A0-EB4146C1FDC5Q46934931-63DEBC2D-B6DB-4299-82FE-2018EB79013AQ46970305-DFD5197D-4B4C-4E88-ACE1-67DDC6AACEA9Q56977976-55C5B7CC-387B-4F64-B326-5894F6051F0CQ57076696-A4011E2F-4513-45DE-A541-0A5637DF1995
P2860
Improved pulmonary function in systemic sclerosis after treatment with cyclophosphamide.
description
1994 nî lūn-bûn
@nan
1994 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Improved pulmonary function in systemic sclerosis after treatment with cyclophosphamide.
@ast
Improved pulmonary function in systemic sclerosis after treatment with cyclophosphamide.
@en
type
label
Improved pulmonary function in systemic sclerosis after treatment with cyclophosphamide.
@ast
Improved pulmonary function in systemic sclerosis after treatment with cyclophosphamide.
@en
prefLabel
Improved pulmonary function in systemic sclerosis after treatment with cyclophosphamide.
@ast
Improved pulmonary function in systemic sclerosis after treatment with cyclophosphamide.
@en
P2093
P356
P1476
Improved pulmonary function in systemic sclerosis after treatment with cyclophosphamide.
@en
P2093
P304
P356
10.1002/ART.1780370518
P577
1994-05-01T00:00:00Z